International evidence-based guidelines include 166 recommendations and practice points to improve health outcomes of women with PCOS.
These analyses may serve clinicians in addressing potential psychiatric obstacles in patients undergoing fertility treatments.
Researchers identified factors associated with regret following elective oocyte cryopreservation among 201 women undergoing fertility preservation between 2012 and 2016.
Researchers tested whether semen quality and reproductive function could be a marker of general health in men.
Variable improvements in menses, hormones, and metabolism were seen during 24 months of metformin use in 119 women with PCOS sub-grouped by baseline weight and androgen status.
Study raises the question of whether treatment with thyroid hormone replacement for individuals with TSH levels >2.5 mIU/L may be an economical first step in treating unexplained infertility.
Researchers used the Family Planning Estimation Tool to evaluate the performance of 68 of the 69 countries involved in the Family Planning 2020 initiative.
Although the use of fertility therapy has steadily increased in the past few decades, research findings pertaining to related long-term cardiovascular outcomes are scarce and conflicting.
Women with hypertensive disorders during pregnancy have a significantly greater risk for future cardiovascular disease when compared with normotensive expecting mothers.
Between 2005 and 2014, the prevalence of chronic conditions increased across all segments of the childbearing population.
Long-term exposure to progestin-only oral contraceptives or to a progestin intrauterine device is associated with a small beneficial effect on pelvic girdle pain.
Asthma may increase the likelihood of a woman needing fertility treatments prior to becoming pregnant.
The prohibition of mitochondrial replacement therapy may unfairly impact women with mitochondrial disorders who are undergoing IVF.
Researchers examined the efficacy of FlexibleMIB (ethinylestradiol/drospirenone) vs placebo as therapy for endometriosis-related pain.
High costs associated with in vitro fertilization create barriers to fertility treatments that many cannot overcome.
Ten randomized controlled trials were examined to determine the efficacy and safety of glyburide vs insulin treatment for gestational diabetes.
Contraception conversations should take place as early as is appropriate.
Researchers are examining the potential of CRISPR-Cas9 gene editing to treat and prevent other genetic diseases.
A combination of early menstruation with more frequent periods may lower a woman's depression risk.
Gonadotropin-releasing hormone antagonist elagolix demonstrated clinical improvement for women with endometriosis-related pain.
The fewer menstrual cycles women had over a lifetime placed them at greater risk for incident heart failure.
Data from a systematic review and meta-analysis confirmed a higher risk of anxiety and depression in PCOS, but underlying factors are still unclear.
The relationship between hormones and migraine is most frequently pronounced during the female reproductive years.
The presence of non-Lactobacillus microbiota was associated with significant decreases in implantation.
Endocrinology Advisor Articles
- Second-Line Therapies Show Benefit Over Metformin Monotherapy in T2D
- ADA Releases Updated Guidelines for Managing Pediatric Type 1 Diabetes
- Relationship Between HbA1c and Coronary Artery Disease
- Intermittent vs Continuous Energy-Restricted Diet: Effects on Glycemic Control and Weight Loss T2D
- The Obesity Paradox in Diabetes: Conceptual and Clinical Approaches
- Appetite Awareness Training May Enhance Behavioral Strategies in Childhood Obesity
- Cost-Benefit Analysis of Insulin Analogs in Type 2 Diabetes
- Insurance Status Tied to Higher Self-Perceived Poor/Fair Health
- Characteristics of Menstrual Cycle Associated With Early Natural Menopause
- Decreased Osteoporosis Treatment Initiation Observed After Hip Fracture